Literature DB >> 2332562

Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure.

C Svensson1, M Andersson, C G Persson, P Venge, U Alkner, U Pipkorn.   

Abstract

This study examined plasma- and eosinophil-derived products in nasal lavage fluids obtained from patients with hay fever during natural allergen exposure. Nine patients with strictly seasonal allergic rhinitis and five normal, nonallergic subjects (control group) were studied. Nasal lavages were performed twice weekly, starting 1 week before the expected birch-pollen season and continuing for 6 weeks, thereby covering the entire birch-pollen season. Nasal symptoms and pollen counts were recorded daily. The lavage fluid was analyzed for it content of albumin, bradykinins, and eosinophil cationic protein (ECP). During the pollen season, each of these solutes was significantly increased in the nasal lavage fluid from the allergic patients (p less than 0.05) but not from the control subjects. Albumin, bradykinins, and ECP generally correlated better between themselves than with symptoms and pollen counts. We conclude that natural exposure to allergens induces plasma exudation and increased levels of ECP on the human nasal mucosa.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2332562     DOI: 10.1016/0091-6749(90)90064-b

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  19 in total

1.  The use of the nose to study the inflammatory response of the respiratory tract.

Authors:  C G Persson; C Svensson; L Greiff; M Anderson; P Wollmer; U Alkner; I Erjefält
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

2.  [The NTP in allergy research : open questions regarding nasal provocation tests using allergens].

Authors:  U Förster; A Sperl; L Klimek
Journal:  HNO       Date:  2013-10       Impact factor: 1.284

3.  Pollen count and presentation of angiotensin-converting enzyme inhibitor-associated angioedema.

Authors:  Brittany Straka; Hui Nian; Chantel Sloan; James Brian Byrd; Alencia Woodard-Grice; Chang Yu; Elizabeth Stone; Gary Steven; Tina Hartert; Koon K Teo; Guillaume Pare; Catherine A McCarty; Nancy J Brown
Journal:  J Allergy Clin Immunol Pract       Date:  2013-06-21

4.  Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen-induced nasal blockage.

Authors:  C E Austin; J C Foreman; G K Scadding
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

5.  A two-year course of specific immunotherapy or of continuous antihistamine treatment reverse eosinophilic inflammation in severe persistent allergic rhinitis.

Authors:  M Lauriello; P Muzi; L Di Rienzo; C Di Stanislao; G Coen Tirelli; M Bologna
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-10       Impact factor: 2.124

6.  A study of the action of bradykinin and bradykinin analogues in the human nasal airway.

Authors:  C E Austin; J C Foreman
Journal:  J Physiol       Date:  1994-07-15       Impact factor: 5.182

7.  Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation.

Authors:  A J Coyle; S J Ackerman; R Burch; D Proud; C G Irvin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

8.  Comparative nasal effects of bradykinin, kallidin and [Des-Arg9]-bradykinin in atopic rhinitic and normal volunteers.

Authors:  K Rajakulasingam; R Polosa; S T Holgate; P H Howarth
Journal:  J Physiol       Date:  1991-06       Impact factor: 5.182

Review 9.  The kinin system in rhinitis and asthma.

Authors:  D Proud
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

10.  Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients.

Authors:  D Wang; P Clement; J Smitz; M P Derde
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.